Sun Pharma has received CCI approval for selling two CNS divisions to Strides
Sun Pharma has got the Competition Commission of India’s approval to sell the erstwhile Ranbaxy Laboratories’ two divisions in the Central nervous system (CNS) segment...
Use UNICORN Signals App
By EquityPandit
